EBIT: Income before interest and taxes.
Yubo International Biotech Limited (YBGJ) had EBIT of $-0.16M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-0.14M |
|
-- |
|
-- |
|
$0.17M |
|
$-0.17M |
|
$-0.00M |
|
$-0.16M |
|
$-0.16M |
|
$-0.16M |
|
$-0.16M |
|
$-0.16M |
|
$-0.16M |
|
|
EBIT |
$-0.16M |
$-0.13M |
|
139.64M |
|
139.64M |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$0.67M |
|
$0.04M |
|
$0.18M |
|
$0.85M |
|
$2.79M |
|
-- |
|
-- |
|
$2.79M |
|
$-1.94M |
|
$-1.99M |
|
$-1.94M |
|
170.42M |
|
| Cash Flow Statement Financials | |
$-0.84M |
|
-- |
|
$0.85M |
|
$0.01M |
|
$0.01M |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
8.27% |
|
8.09% |
|
-18.98% |
|
8.27% |
|
$-0.01 |
|
$-0.01 |
|
$-0.01 |
|